
Though it may be difficult to talk about, ED affects nearly 1 in 5 men over the age of 20 in the U.S. This condition can impact not only your sex life, but also your confidence. Now, local doctors are conducting the REVIVE research study to evaluate an investigational medication for treating ED.
To be eligible for the REVIVE research study, you must:
- Be 18 years of age or older
- Have had mild to severe ED for at least 6 months, AND
- Be in a monogamous, heterosexual relationship for at least 3 months.
Men with type 1 or type 2 diabetes could be eligible and are encouraged to inquire about this research study.
You will not be allowed to participate in this research study if your partner is pregnant, breast-feeding, or wishes to become pregnant. Qualified participants will receive study medication as well as study-related medical evaluations at no cost. Reimbursement for time and travel may also be provided.
To see if you qualify please call:
AdvanceMed Research
2 Princess Road, Suite J
Lawrenceville, NJ 08648
Telephone: 609-895-0735
Fill out our Volunteer Form to receive information on how to participate in one of our clinical trials.
Current Studies
Overactive Bladder
• Botox for Bladder Incontinence & Frequency
• Is Overactive Bladder a Part of Your Life?
• Nocturia - Waking Up at Night to Urinate
• Women, Overactive Bladder (OAB)
• Overactive Bladder with Urgency
• Single Bladder Instillation for OAB
• Overactive Bladder No Placebo
• Non-invasive Neurostimulator for OAB
• Topical Gel for Treatment of OAB
• Stress Urinary Incontinence
Erectile Dysfunction
Low Testosterone
Prostate Problems
• BPH
• BPH
Prostate Cancer
• Prostate Cancer requiring Hormone Therapy
• Prevention of Metastatic Disease
• Prostate Cancer with Metastatic Disease
Bladder Cancer
• Intravesical Treatment of non-Invasive Bladder Cancer
• Recurrent Bladder Cancer after BCG Treatment
Women's Health Issues
• Decreased Sexual Desire
Neurological Health Issues
• Parkinson's Disease Movement/Balance